Neurology Residency
The Mirken Department of Neurology’s residency program is based at Beth Israel Medical Center, the Manhatten campus for the Albert Einstein College of Medicine. The majority of inpatient rotations take place at our Petrie Campus, located at First Avenue and 16th Street. Our residents also have some rotations at our sister institution, Roosevelt Hospital, which is located on the upper west side of Manhattan.

The neurology outpatient department is housed at the Phillips Ambulatory Care Center (PACC), located in the heart of Union Square. The neurology department recently completed a state-of-the-art multi-million dollar expansion at PACC to accommodate the expanding faculty and residency program.

Our department is devoted to the education of young neurologists. Our faculty have trained at outstanding neurology programs and are professors at the Albert Einstein College of Medicine. Many of our faculty are nationally and internationally renowned in their respective subspecialties. Aside from clinical practice, the department is committed to clinical research. Consequently, we provide multiple opportunities for our residents to participate in original research and we support them in attending local and national meetings.

Quality of life is important to us. New York is one of the most exciting, culturally diverse, and safe cities in the world. Living in Manhattan, or one of the surrounding boroughs, affords our residents access to literally thousands of restaurants, shows, museums, bars, clubs, shops, and concerts. In addition, with close proximity to the Hudson and East Rivers, as well as Central Park, the opportunity for outside activities is endless.

Beth Israel offers numerous unique benefits to its residents, including guaranteed subsidized housing; a salary that is one of the highest in the area; free health insurance to residents and their families; paid travel to conferences; hospital and school of medicine library access; and paid membership in the American Academy of Neurology.

Learn About Our Neurology Residency

Movement Disorders Fellowship
Under the direction of our Department Chair and internationally known Movement Disorders specialist Susan Bressman, MD, The Mirken Department of Neurology’s Movement Disorder Fellowship offers unique opportunities to develop clinical excellence in the treatment of all movement disorders and to participate in clinical research and clinical trials. This fellowship is a one to two-year program. The first year is primarily devoted to the development of clinical expertise in movement disorders. During the second year, fellows are encouraged to pursue research interests.

Under one-to-one supervision with the Movement Disorders' faculty, fellows actively participate in the evaluation, diagnosis, and management of our patients. The focus is on outpatient diagnosis and treatment. Inpatients are also seen on a consultative basis. Our patients include referrals of diagnostic dilemmas and therapeutic challenges from throughout the United States as well as other countries. We have over 3,000 patient visits a year.

Fellows have the opportunity to see patients with a breadth of movement disorders, including Parkinson’s disease, Parkinsonism, dystonia, tremor, tics, ataxia, chorea, tardive syndromes, myoclonus, and restless leg syndrome, as well as paroxysmal and psychogenic movement disorders. Fellows have significant exposure to treatment with Botulinum toxin and deep brain stimulation.

Throughout the course of the fellowship, fellows are encouraged, with faculty support, to pursue individual interests and develop novel research or to become actively involved with current ongoing research. Ongoing movement disorder research includes the genetics and epidemiology of dystonia, Parkinson’s disease, and essential tremor.

Additionally, clinical and research training is supplemented with weekly videotape rounds and teaching conferences.

Core faculty include: Susan Bressman, MD, Rachel Saunders-Pullman, MD, Lawrence Severt, MD, Vicki Shanker, MD, Naomi Lubarr, MD (pediatric movement disorders), Mark Groves, MD (neuro-psychiatry) and Christina Palmese, Phd (neuro-psychology).